Speaker Details

Elizabeth Gates Berry, MD, FAAD

Elizabeth Gates Berry, MD, FAAD

Oregon Health & Science University; Portland VA Medical Center

BIOGRAPHY

Dr. Berry has dedicated her career to treating patients with melanoma and those who are at high risk for the disease. She chose the field of dermatology because she believes that early detection of skin cancer is the best chance for a cure. Dr. Berry completed her medical degree and internship at Vanderbilt University and her dermatology residency at Emory University. She currently serves as OHSU Pigmented Lesion Clinic Director, Melanoma Multidisciplinary Clinic Co-Director, and Co-Director of the GenoMEL consortium, an international group of dermatologists, medical oncologists, basic scientists and clinical geneticists dedicated to pursuing the germline and somatic genetic underpinnings of melanoma. Her clinical and research interests include UV protection (clothing and sunscreen), management of histologically atypical nevi, melanoma education for primary care clinicians, dermoscopy education, guidelines for germline genetic testing for melanoma predisposition syndromes, and treatment of large, unresectable melanomas and cutaneous melanoma metastases.

SESSIONS

S031 Melanoma in 2027
Mar 20, 2027 • 1:00 PM - 4:00 PM
U073 Markers of Risk, Not Pre-Melanomas: Case-Based Management of Dysplastic Nevi
Mar 22, 2027 • 7:30 AM - 8:30 AM

DISCLOSURES

Merck & Co., Inc – Advisory Board(Fees); Orlucent – Investigator(Grants/Research Funding);